Diabetes and the elderly brain: Sweet memories?

Therapeutic Advances in Endocrinology and Metabolism

Volumn 3, Issue 6, 2012, Pages 189-196

  Samaras, Katherine ^a   Sachdev, Perminder S ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Brain; brain volume; cognition; dementia; diabetes; glucose; impaired fasting glucose; inflammation

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; C REACTIVE PROTEIN; GLUCOCORTICOID; GLUCOSE; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; DECISION MAKING; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EXECUTIVE FUNCTION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MILD COGNITIVE IMPAIRMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SELF CARE; SENESCENCE; VERBAL MEMORY;

EID: 84871497865     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018812469645     Document Type: Article

References (65)

1. Arvanitakis Z. Wilson R. Bienias J. Evans D. Bennett D. (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61: 661–666.
2. Alzheimer's Disease International (2011) World Alzheimer Report 2011. Prince M. Bryce R. Ferri C. (eds). London: Alzheimer's Disease International.
3. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington DC: APA.
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: APA.
5. Biessels G. Staekenborg S. Brunner E. Brayne C. Scheltens P. (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5: 64–74.
6. Blair C. Folsom A. Knopman D. Bray M. Mosley T. Boerwinkle E. (2005) APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64: 268–276.
7. Brayne C. Gill C. Huppert F. Barkley C. Gehlhaar E. Girling D. et al. (1998) Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord 9: 175–180.
8. Bruce D. Davis W. Casey G. Clarnette R. Brown S. Jacobs I. et al. (2009) Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 52: 1808–1815.
9. Bucht G. Adolfsson R. Lithner F. Winblad B. (1983) Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 213: 387–392.
10. Cherbuin N. Sacdev P. Anstey K. (2012) Higher fasting plasma glucose is associated with hippocampal atrophy. Neurology 79: 1019–1026.
11. Christman A. Matsushita K. Gottesman R. Mosley T. Lonso A. Coresh J. et al. (2011) Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 54: 1645–1652.
12. Craft S. Watson G. (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3: 169–178.
13. de Bresser J. Tiehuis A. van Den Berg E. Reijmer Y. Jongen C. Kappelle L. et al. (2010) Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 33: 1309–1314.
14. Ding J. Strachan M. Reynolds R. Frier B. Deary I. Fowkes F. et al. (2010) Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59: 2883–2889.
15. Elias P. Elias M. D'Agostino R. Cupples L. Wilson P. Silbershatz H. et al. (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 20: 1388–1395.
16. Espeland M. Miller M. Goveas J. Hogan P. Coker L. Williamson J. et al. (2011) Cognitive function and fine motor speed in older women with diabetes mellitus: results from the Women's health initiative study of cognitive aging. J Womens Health (Larchmt) 20: 1435–1443.
17. Euser S. Sattar N. Witteman J. Bollen E. Sijbrands E. Hofman A. et al. (2010) A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 59: 1601–1607.
18. Fischer A. de Frias C. Yeung S. Dixon R. (2009) Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes. J Clin Exp Neuropsychol 31: 809–822.
19. Folstein M. Folstein S. McHugh P. (1975) ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
20. Gregg E. Yaffe K. Cauley J. Rolka D. Blackwell T. Narayan K. Cummings S. (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160: 174–180.
21. Grodstein F. Chen J. Wilson R. Manson J. (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24: 1060–1065.
22. Haan M. Shemanski L. Jagust W. Manolio T. Kuller L. (1999) The role of APOE epsilon 4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282: 40–46.
23. Halliday G. Robinson S. Shepherd C. Kril J. (2000) Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27: 1–8.
24. Hassing L. Grant M. Hofer S. Pedersen N. Nilsson S. Berg S. et al. (2004) Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 10: 599–607.
25. Hassing L. Johansson B. Nilsson S. Berg S. Pedersen N. Gatz M. McClearn G. (2002) Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr 14: 239–248.
26. Kanaya A. Barrett-Connor E. Gildengorin G. Yaffe K. (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164: 1327–1333.
27. Kloppenborg R. van Den Berg E. Kappelle L. Biessels G. (2008) Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 585: 97–108.
28. Launer L. Miller M. Williamson J. Lazar R. Gerstein H. Murray A. et al. (2011) Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 10: 969–977.
29. Lesage S. Mosley T. Wong T. Szklo M. Knopman D. Catellier D. et al. (2009) Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 73: 862–868.
30. Luchsinger J. Reitz C. Patel B. Tang M. Manly J. Mayeux R. (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64: 570–575.
31. Luchsinger J. Tang M. Stern Y. Shea S. Mayeux R. (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154: 635–641.
32. MacKnight C. Rockwood K. Awalt E. McDowell I. (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14: 77–83.
33. Manschot S. Biessels G. de Valk H. Algra A. Rutten G. van der Grond J. et al. (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50: 2388–2397.
34. Manschot S. Brands A. van der Grond J. Kessels R. Algra A. Kappelle L. et al. (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55: 1106–1113.
35. Marioni R. Strachan M. Reynolds R. Lowe G. Mitchell R. Fowkes F. et al. (2010) Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59: 710–713.
36. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan E. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944.
37. Okereke O. Kang J. Cook N. Gaziano J. Manson J. Buring J. Grodstein F. (2008) Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc 56: 1028–1036.
38. Ott A. Stolk R. van Harskamp F. Pols H. Hofman A. Breteler M. (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53: 1937–1942.
39. Park C. Seeley R. Craft S. Woods S. (2000) Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68: 509–514.
40. Peila R. Rodriguez B. Launer L. (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51: 1256–1262.
41. Petersen R. Roberts R. Knopman D. Boeve B. Geda Y. Ivnik R. et al. (2009) Mild cognitive impairment: ten years later. Arch Neurol 66: 1447–1455.
42. Reijmer Y. van Den Berg E. Ruis C. Kappelle L. Biessels G. (2010) Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26: 507–519.
43. Ritchie K. Touchon J. (2000) Mild cognitive impairment: conceptual basis and current nosological status. Lancet 355: 225–228.
44. Roman G. Tatemichi T. Erkinjuntti T. Cummings J. Masdeu J. Garcia J. et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250–260.
45. Schmidt R. Launer L. Nilsson L. Pajak A. Sans S. Berger K. et al. (2004) Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53: 687–692.
46. Schram M. Euser S. de Craen A. Witteman J. Frolich M. Hofman A. et al. (2007) Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55: 708–716.
47. Sima A. (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetol 47: 279–293.
48. Singh B. Rajakumar P. Eves E. Rosner M. Wainer B. Devaskar S. (1997) Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regul Pept 69: 7–14.
49. Solfrizzi V. Panza F. Colacicco A. D'Introno A. Capurso C. Torres F. et al. (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63: 1882–1891.
50. Steinman M. Lee S. John Boscardin W. Miao Y. Fung K. Moore K. et al. (2012) Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc 60: 1872–1880.
51. Strachan M. (2011) R D Lawrence Lecture 2010. The brain as a target organ in type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet Med 28: 141–147.
52. Strachan M. Reynolds R. Marioni R. Price J. (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7: 108–114.
53. Thomas M. Walker M. Emberson J. Thomson A. Lawlor D. Ebrahim S. et al. (2005) Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med 22; 789–793.
54. Tiehuis A. van der Graaf Y. Visseren F. Vincken K. Biessels G. Appelman A. et al. (2008) Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 39: 1600–1603.
55. van Den Berg E. Reijmer Y. de Bresser J. Kessels R. Kappelle L. Biessels G. (2010) A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53: 58–65.
56. Wallum B. Taborsky G. Jr Porte D. Jr Figlewicz D. Jacobson L. Beard J. et al. (1987) Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 64: 190–194.
57. Whitehouse P. (2007) Mild cognitive impairment – a confused concept? Nat Clin Pract Neurol 3: 62–63.
58. Whitmer R. Karter A. Yaffe K. Quesenberry C. Jr Selby J. (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301: 1565–1572.
59. Wolf-Klein G. Siverstone F. Brod M. Levy A. Foley C. Termotto V. et al. (1988) Are Alzheimer patients healthier? J Am Geriatr Soc 36: 219–224.
60. Xu W. Qiu C. Wahlin A. Winblad B. Fratiglioni L. (2004) Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63: 1181–1186.
61. Yaffe K. Blackwell T. Kanaya A. Davidowitz N. Barrett-Connor E. Krueger K. (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63: 658–663.
62. Yaffe K. Blackwell T. Whitmer R. Krueger K. Barrett Connor E. (2006) Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10: 293–295.
63. Yaffe K. Falvey C. Hamilton N. Schwartz A. Simonsick E. Satterfield S. et al. (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69: 1170-1175.
64. Yaffe K. Haan M. Blackwell T. Cherkasova E. Whitmer R. West N. (2007) Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55: 758–762.
65. Yoshitake T. Kiyohara Y. Kato I. Ohmura T. Iwamoto H. Nakayama K. et al. (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45: 1161–1168.